LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
SK-BR-3 Dasatinib
3.33
uM
LJP5
 2
D02
 72
hr
 2543 4047 5578 0.7254 0.4954
SK-BR-3 Dasatinib
3.33
uM
LJP5
 3
D02
 72
hr
 2543 4346 5578 0.7790 0.5939
SK-BR-3 Dasatinib
3.33
uM
LJP6
 1
I02
 72
hr
 2543 2947 5578 0.5283 0.1330
SK-BR-3 Dasatinib
3.33
uM
LJP6
 2
I02
 72
hr
 2543 3334 5578 0.5976 0.2605
SK-BR-3 Dasatinib
3.33
uM
LJP6
 3
I02
 72
hr
 2543 3490 5578 0.6256 0.3119
SK-BR-3 Dovitinib
3.33
uM
LJP5
 1
E20
 72
hr
 2543 3481 5578 0.6240 0.3089
SK-BR-3 Dovitinib
3.33
uM
LJP5
 2
E20
 72
hr
 2543 3234 5578 0.5797 0.2275
SK-BR-3 Dovitinib
3.33
uM
LJP5
 3
E20
 72
hr
 2543 3719 5578 0.6667 0.3873
SK-BR-3 Enzastaurin
3.33
uM
LJP5
 1
D14
 72
hr
 2543 5546 5578 0.9941 0.9892
SK-BR-3 Enzastaurin
3.33
uM
LJP5
 2
D14
 72
hr
 2543 5901 5578 1.0578 1.1062
SK-BR-3 Enzastaurin
3.33
uM
LJP5
 3
D14
 72
hr
 2543 5902 5578 1.0580 1.1065
SK-BR-3 Erlotinib
3.33
uM
LJP5
 1
M20
 72
hr
 2543 5643 5578 1.0115 1.0212
SK-BR-3 Erlotinib
3.33
uM
LJP5
 2
M20
 72
hr
 2543 5633 5578 1.0097 1.0179
SK-BR-3 Erlotinib
3.33
uM
LJP5
 3
M20
 72
hr
 2543 5547 5578 0.9943 0.9896
SK-BR-3 Foretinib
3.33
uM
LJP5
 1
H08
 72
hr
 2543 2174 5578 0.3897 -0.1217
SK-BR-3 Foretinib
3.33
uM
LJP5
 2
H08
 72
hr
 2543 2036 5578 0.3650 -0.1672
SK-BR-3 Foretinib
3.33
uM
LJP5
 3
H08
 72
hr
 2543 2301 5578 0.4125 -0.0799
SK-BR-3 R406
3.33
uM
LJP6
 1
C14
 72
hr
 2543 5601 5578 1.0040 1.0074
SK-BR-3 R406
3.33
uM
LJP6
 2
C14
 72
hr
 2543 5611 5578 1.0058 1.0107
SK-BR-3 R406
3.33
uM
LJP6
 3
C14
 72
hr
 2543 5314 5578 0.9526 0.9128
SK-BR-3 Pictilisib
3.33
uM
LJP6
 1
D20
 72
hr
 2543 2072 5578 0.3714 -0.1553
SK-BR-3 Pictilisib
3.33
uM
LJP6
 2
D20
 72
hr
 2543 2071 5578 0.3712 -0.1557
SK-BR-3 Pictilisib
3.33
uM
LJP6
 3
D20
 72
hr
 2543 2138 5578 0.3833 -0.1336
SK-BR-3 Gefitinib
3.33
uM
LJP6
 1
N08
 72
hr
 2543 2873 5578 0.5150 0.1086
SK-BR-3 Gefitinib
3.33
uM
LJP6
 2
N08
 72
hr
 2543 3529 5578 0.6326 0.3247